The Patent Finder

Rin Institute Inc.

Also on record
Records under this name other than the patents Rin Institute Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 4 of 4 · Back to Rin Institute Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,192,956Antibody Binding to TMEM132A, Anticancer Agent, and Cancer Test Method
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,509,507Fusion Protein Suitable for Dissolving Fibrin Clot, and Pharmaceutical Composition Containing Said Fusion Protein
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,377,504Antibody Beneficial for Treatment of Solid Tumors, Antibody-Drug Conjugate, and Cancer Drug Including Same
Lapsed on the fee record
Ended Jul 5, 2026 · High confidence
Lapsed on the fee recordEnded Jul 5, 2026High confidence
US 11,311,626Plasmin-cleavable anti-insoluble fibrin antibody-drug conjugate
Lapsed on the fee record
Ended Apr 26, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 26, 2026USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited